(Q34135760)

31 July 2017

1 reference

title

The cutaneous pathology of lupus erythematosus: a review (English)

1 reference

31 July 2017

0 references

1 reference

Crowson AN

1

1 reference

PubMed ID

11168747

31 July 2017

Magro C

series ordinal

2

1 reference

31 July 2017

1 January 2001

1 reference

Journal of Cutaneous Pathology

31 July 2017

1 reference

31 July 2017

28

1 reference

31 July 2017

1-23

1 reference

31 July 2017

1

1 reference

The 1982 revised criteria for the classification of systemic lupus erythematosus

31 July 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Histopathologic comparison of the subsets of lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Frequency of systemic lupus erythematosus in different ethnic groups in hawaii

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Widespread pruritic plaques in a patient with subacute cutaneous lupus erythematosus and hypocomplementemia: response to dapsone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Leukocytoclastic vasculitis in subacute cutaneous lupus erythematosus: clinicopathologic study of three cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Recent advances in the pathology of cutaneous drug eruptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Paraneoplastic subacute cutaneous lupus erythematosus: report of a case associated with cancer of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

SSA/Ro antigen expression in simian virus 40-transformed human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Calcium regulation of growth and differentiation of mouse epidermal cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Linear cutaneous lupus erythematosus in an adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Linear childhood discoid lupus erythematosus following the lines of Blaschko: a case report with review of the linear manifestations of lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Vasculitis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Sterile neutrophilic folliculitis with perifollicular vasculopathy: a distinctive cutaneous reaction pattern reflecting systemic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

The prevalence of antibodies to anionic phospholipids in patients with the primary antiphospholipid syndrome, systemic lupus erythematosus and their relatives and spouses

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Antiphospholipid (Hughes) syndrome in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Widespread cutaneous necrosis associated with antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

A practical guide for serologic evaluation of autoimmune connective tissue diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Molecular properties of the Ro/SSA antigen and enzyme-linked immunosorbent assay for quantitation of antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

The demonstration of SS-A/Ro antigen in human fetal tissues and in neonatal and adult skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Significance of the Ro antigen system

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Significance of the anti-Ro (SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Chilblain lupus erythematosus of Hutchinson responding to surgical treatment: a report of two patients with anti-Ro/SS-A antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Immunofluorescent "band" test for lupus erythematosus. II. Employing skin lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Cutaneous immunopathology. The diagnostic use of direct and indirect immunofluorescence techniques in dermatologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

The specificity and clinical usefulness of the lupus band test

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Lupus band test: clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Lupus band test in untreated SLE patients: correlation of immunoglobulin deposition in the skin of the extensor forearm with clinical renal disease and serological abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

The Significance of Cutaneous Immunoglobulin Deposits In Lupus Erythematosus And Nzb/Nzw F1 Hybrid Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

The molecular basis of the SSA/Ro antigens and the clinical significance of their autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Antibody-dependent cellular cytotoxicity and skin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Pathomechanisms of photosensitive lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Bullous systemic lupus erythematosus. Report of a case with lupus erythematosus cells in the dermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Lymphomatoid granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Generalized lupus panniculitis and antiphospholipid syndrome in a patient without complement deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Verapamil inhibition of lymphocyte proliferation and function in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Impaired T cell capping and receptor regeneration in active systemic lupus erythematosus. Evidence for a disorder intrinsic to the T lymphocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Methyldopa inhibition of suppressor-lymphocyte function: a proposed cause of autoimmune hemolytic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Lymphocyte alteration by procainamide: relation to drug-induced lupus erythematosus syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Immunomodulatory effect of procainamide in man. Inhibition of human suppressor T-cell activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Immune Responses to Hydralazine and Nuclear Antigens in Hydralazine-Induced Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

The cutaneous manifestations of human parvovirus B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Bullous disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

Subacute Cutaneous Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Distinctive cutaneous subsets in the spectrum of lupus erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Classification of lupus erythematosus based upon cutaneous manifestations. Dermatological, systemic and laboratory findings in 191 patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Discoid lupus erythematosus as part of a larger disease spectrum. Correlation of clinical features with laboratory findings in lupus erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Selective expansions of T cells expressing V beta 8 and V beta 13 in skin lesions of patients with chronic cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

The epidemiology of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Cutaneous manifestations of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Chilblain lupus erythematosus: report of 15 cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Idiopathic perniosis and its mimics: a clinical and histological study of 38 cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Urticarial vasculitis: a histopathologic and clinical review of 72 cases.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Subacute cutaneous lupus erythematosus presenting as erythroderma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Subacute cutaneous lupus erythematosus presenting with generalized poikiloderma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Photosensitivity in lupus erythematosus, UV photoprovocation results compared with history of photosensitivity and clinical findings

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Diltiazem and subacute cutaneous lupus erythematosus-like lesions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

The cutaneous pathology associated with seropositivity for antibodies to SSA (Ro): a clinicopathologic study of 23 adult patients without subacute cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Mixed connective tissue disease. A clinical, histologic, and immunofluorescence study of eight cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

1 reference

7 January 2021

Tumid lupus erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Linear cutaneous lupus erythematosus following the lines of Blaschko

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Abnormal laboratory test results and their relationship to prognosis in discoid lupus erythematosus. A long-term follow-up study of 92 patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Histocompatibility antigens in discoid and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Hypertrophic discoid lupus erythematosus resembling squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Benign cutaneous Degos' disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Cutaneous papules and nodules in the diagnosis of the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Reactive angioendotheliomatosis in association with the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Systemic lupus erythematosus with anti-Ro antibodies: clinical, histologic and immunologic findings. Report of three cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Clinical and biologic significance of antibodies to Ro/SSA

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Two types of inflammatory vascular disease in Sjögren's syndrome. Differential association with seroreactivity to rheumatoid factor and antibodies to Ro (SS-A) and with hypocomplementemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-up

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Cutaneous lupus erythematosus: comparison of direct immunofluorescence findings with histopathology

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

The clinical utility of the lupus band test

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Occurrence of positive immunofluorescence in the dermo-epidermal junction of sun-exposed skin of normal adults

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Lupus band test: anatomic regional variations in discoid lupus erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

The immunofluorescent profile of dermatomyositis: a comparative study with lupus erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Immunopathologic findings in systemic sclerosis patients: clinical and immunopathologic relationships

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Deposition of membrane attack complex in cutaneous lesions of lupus erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Deposition of membrane attack complex in cutaneous lesions of lupus erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Dust-like particles: a specific direct immunofluorescence pattern in sub-acute cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Improved detection of anti-Jo-1 antibody, a marker for myositis, using purified histidyl-tRNA synthetase

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Serum complement activation in central nervous system disease in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Bullous eruption of systemic lupus erythematosus: a clinicopathological study of four cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Bullous systemic lupus erythematosus: revised criteria for diagnosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Bullous systemic lupus erythematosus: an unusual clinical course and detectable circulating autoantibodies to the epidermolysis bullosa acquisita antigen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the noncollagenous (NC1) domain

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Bullous systemic lupus erythematosus: detection of antibodies against noncollagenous domain of type VII collagen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Atypical lymphoid infiltrates arising in cutaneous lesions of connective tissue disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

The histopathology of lupus erythematosus panniculitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Lupus erythematosus panniculitis (profundus)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Lupus Erythematosus Panniculitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Panniculitis and Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

5-Methylcytosine content of DNA in blood, synovial mononuclear cells and synovial tissue from patients affected by autoimmune rheumatic diseases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Subacute cutaneous lupus erythematosus-like drug eruption due to combination diuretic hydrochlorothiazide and triamterene

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Lichenoid and subacute cutaneous lupus erythematosus-like dermatitis associated with antihistamine therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Differential protective action of cytokines on radiation-induced apoptosis of peripheral lymphocyte subpopulations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

Granuloma annulare and necrobiosis lipoidica tissue reactions as a manifestation of systemic disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.280101.X

7 January 2021

10.1034/J.1600-0560.2001.280101.X

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11168747